NR3C2 and hydrops fetalis: Analysis of HF medications in ATTR‐CA demonstrated that neurohormonal modulation through mineralocorticoid receptor antagonists and low‐dose β‐blockers in patients with an LVEF ≤40% was associated with improved survival; and suggests ATTR‐CA may share similar pathophysiological mechanisms to HF of different causes.23